Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation.
about
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2.Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.Osteopontin in systemic sclerosis and its role in dermal fibrosisPeripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.The role of the acquired immune response in systemic sclerosis.Basal Activation of Type I Interferons (Alpha2 and Beta) and 2'5'OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic SclerosisDifferential upregulation of human 2'5'OAS genes on systemic sclerosis: Detection of increased basal levels of OASL and OAS2 genes through a qPCR based assay.A cell model system to study regulation of phosphotidylinositol 3-kinase and protein kinase B activity by cytokines/growth factors produced by type I collagen stimulated immune cells from patients with systemic sclerosis.Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls.Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis.Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis.Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist's, Clinician's, and Patient's Perspective.Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response.
P2860
Q35257518-9A18909C-BB81-4FDE-B89A-005B08B2F47DQ35554387-6FE9CA27-B644-4E24-9ADA-9CD448DBCAC7Q36002290-D63F3480-D6BE-4778-8557-47E1E6BD0DA7Q36307704-633AB91F-69E6-4640-BC69-B97DD0A09B71Q36691117-C096529B-712F-4469-823B-F2EE51243FC4Q37143961-C335CF30-8F69-4466-88A7-51B45E3C310BQ37453883-BA00BBB0-AAD9-4874-89A6-5AEBF3E20B7AQ38543690-8A82F55C-9CFF-4447-BCED-803715D1A27DQ38909742-ADA9B516-85B9-48CA-B104-64E03BA3BD20Q39044473-21D1FA94-72CF-4FDF-AF19-EDE9A8E9949FQ40128186-40E49B3E-55B7-46E5-A8DE-326035748F19Q40491920-ABAE0F54-1935-4005-8802-49D1F3295116Q42490883-19D81A32-7B83-4099-8E7B-59A207DC1505Q48513015-09D6FD1A-E82C-417B-9FD8-72FAA14D6005Q48945028-D3EA7940-3489-4917-8C93-B60F2C37B797Q50230077-D06C04A6-B385-4384-B1F6-7648A2190452Q54375228-F2270D4F-B9D5-4220-BC1F-0E04AF804808
P2860
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@en
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@nl
type
label
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@en
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@nl
prefLabel
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@en
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@nl
P2093
P356
P1476
Peripheral blood T lymphocytes ...... w both Th1 and Th2 activation.
@en
P2093
P2888
P304
P356
10.1023/A:1011024313525
P577
2001-05-01T00:00:00Z
P6179
1012226509